US Senate gives go ahead to device user fees
This article was originally published in Clinica
The US FDA yesterday (October 17) received the go-ahead for charging fees for medical device companies that use its approvals system. The Senate voted unanimously on October 17 in favour of the Medical Device Amendment Bill. It was an amended version of the bill that the House had put forward, as HR 3580, a week earlier (see Clinica No 1028, p 1). The House passed the amended bill in mid-week.